BioCentury
ARTICLE | Financial News

Zixin takes majority stake in Nabsys

July 25, 2016 7:00 AM UTC

Jilin Zixin Pharmaceutical Co. Ltd. (Shanghai:002118) will take a 67% stake in sequencing company Nabsys Inc. (Providence, R.I.) via a $42 million investment, according to a regulatory filing.

Nabsys develops semiconductor-based tools for genome mapping. In March, the company said it had completed a financial restructuring and re-hired founding CEO Barrett Bready. ...